A rating of 82 puts Adaptimmune Therapeutics PLC - ADR (ADAP) near the top of the Biotechnology industry according to InvestorsObserver. Adaptimmune Therapeutics PLC - ADR's score of 82 means it scores higher than 82% of stocks in the industry. Adaptimmune Therapeutics PLC - ADR also received an overall rating of 68, putting it above 68% of all stocks. Biotechnology is ranked 21 out of the 148 industries.
ADAP has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ADAP!